Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Macrolides in the respiratory tract in cystic fibrosis.

× No keyword cloud information.

50 in total

1. In vitro and ex vivo effects of recent and new macrolide antibiotics on chemotaxis of human polymorphonuclear leukocytes.

Authors: D Torre; M Broggini; V Bottà; C Sampietro; R Busarello; C Garberi
Journal: J Chemother Date: 1991-08 Impact factor: 1.714

2. Erythromycin inhibits Cl secretion across canine tracheal epithelial cells.

Authors: J Tamaoki; K Isono; N Sakai; T Kanemura; K Konno
Journal: Eur Respir J Date: 1992-02 Impact factor: 16.671

Review 3. Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.

Authors: N Høiby; C Koch
Journal: Thorax Date: 1990-11 Impact factor: 9.139

4. Quantitative effect of roxithromycin and rifampicin on mucoid cultures from directly plated sputum of cystic fibrosis patients chronically colonized with Pseudomonas aeruginosa.

Authors: M J Dupont; J R Lapointe
Journal: Drugs Exp Clin Res Date: 1990

5. Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes.

Authors: W L Hand; D L Hand; N L King-Thompson
Journal: Antimicrob Agents Chemother Date: 1990-05 Impact factor: 5.191

6. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients.

Authors: Y Ichikawa; H Ninomiya; H Koga; M Tanaka; M Kinoshita; N Tokunaga; T Yano; K Oizumi
Journal: Am Rev Respir Dis Date: 1992-07

7. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation.

Authors: R Anderson
Journal: J Infect Dis Date: 1989-05 Impact factor: 5.226

8. Delta F508 mutation of cystic fibrosis gene is not found in chronic bronchitis with severe obstruction in Japan.

Authors: S Akai; H Okayama; S Shimura; Y Tanno; H Sasaki; T Takishima
Journal: Am Rev Respir Dis Date: 1992-09

9. [Adherence of Pseudomonas aeruginosa to mouse tracheal epithelium--the effect of antimicrobial agents].

Authors: T Yamasaki
Journal: Kansenshogaku Zasshi Date: 1990-05

10. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis.

Authors: H Nagai; H Shishido; R Yoneda; E Yamaguchi; A Tamura; A Kurashima
Journal: Respiration Date: 1991 Impact factor: 3.580

2 in total

Review 1. New therapeutic approaches for cystic fibrosis lung disease.

Authors: Jane C Davies
Journal: J R Soc Med Date: 2002 Impact factor: 5.344

2. Absolute bioavailability and intracellular pharmacokinetics of azithromycin in patients with cystic fibrosis.

Authors: Paul Beringer; Kitty My Tu Huynh; Jane Kriengkauykiat; Luke Bi; Nils Hoem; Stan Louie; Emily Han; Thao Nguyen; Donald Hsu; Purush A Rao; Bertrand Shapiro; Mark Gill
Journal: Antimicrob Agents Chemother Date: 2005-12 Impact factor: 5.191

2 in total